 LAS VEGAS, June 15, 2021 PRNewswire -- JanOne Inc. Nasdaq: JAN, a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. 